Treating Immune-Mediated, Inflammatory Diseases with Janus Kinase (JAK) Inhibitors

by Stefan Ravello | Jul 25, 2024 | Rheumatology

Immune-mediated inflammatory diseases, such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, can prove challenging to address in real-world settings. Although biologics directed against TNF-α can rapidly and sustainably induce clinical...

Achieving Access to High-Quality Care Across the Spectrum of Age and Patient Type to Improve Overall Outcomes for Atopic Dermatitis

by Stefan Ravello | Jul 25, 2024 | Dermatology

Managed care professionals are not on the forefront of dermatologic care for those pediatric and adult patients living with atopic dermatitis. In this program, learners will explore the challenges patients living with atopic dermatitis face and they will identify...

Agents of Change: Improving the Collaboration Among CAR T Center Experts and Community-Based Clinicians for Improved Care of DLBCL Patients

by Stefan Ravello | Jul 25, 2024 | Hematology-Oncology

This dynamic curriculum, detailed by a specialty center clinician, explores each of the CD 19-directed CAR T-cell therapies available for the treatment of DLBCL; solutions to referral and logistic challenges; in-depth early and late toxicity management in CAR T-cell...

Striking a Balance: Understanding Pain Management and Opioids

by Stefan Ravello | Jul 25, 2024 | Opioid Management, Pain Management

Striking a Balance: Understanding Pain Management and Opioids, thoughtfully balances the risks and benefits of safe opioid prescribing. It covers: effective patient assessment, creating patient-centered pain treatment plans, non-pharmaceutical pain treatment options,...

Unlocking The Potential Of Breakthroughs In NSCLC Therapeutic Approaches

by Stefan Ravello | Apr 15, 2024 | Uncategorized

The proposed activities will inform clinicians of recent evidence from clinical trials on the efficacy and safety of TROP2-directed antibody-drug conjugates (ADCs) in patients with progressive NSCLC, allowing them to quickly integrate new treatments into their...